🇺🇸 FDA
Patent

US 8101794

Crystalline forms of a 3-carboxypropyl-aminotetralin compound

granted A61PA61P1/00A61P1/14

Quick answer

US patent 8101794 (Crystalline forms of a 3-carboxypropyl-aminotetralin compound) held by Theravance, Inc. expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P1/00, A61P1/14, A61P25/04, A61P29/00